Annual Quaterly

Annual

Quaterly

Operating Results Financial condition Cash Flows Per share data Major Indicators Segments Data Drug Fostering Program formulations "Growing"formulations Other

Operating Results Financial condition Cash Flows Segments Data Drug Fostering Program formulations "Growing"formulations Other

Per share data

*Japanese GAAP

(Unit：yen)

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
EPS	178.06	179.46	200.55	190.87	179.96	200.40	246.21	215.63	219.83	427.15	376.28
BPS	2,169.13	2,250.34	2,532.11	2,639.59	2,684.38	2,846.58	3,133.97	3,299.42	3,566.54	3,968.05	4,315.88
Annual dividend per share	64	64	64	64	64	64	64	64	85	136	147
Dividends payout ratio	35.9%	35.7%	31.9%	33.5%	35.6%	31.9%	26.0%	29.7%	38.7%	31.8%	39.4%

1.Financial year ends on the 31st March
The total dividend amount includes dividend payments to the executive compensation BIP trust and the stock grant ESOP trust (80 million yen for the fiscal year ending March 2025 and 123 million yen for the fiscal year ending March 2026).
The year-end dividend per share for the fiscal year ending March 2026 has been changed from 76.00 yen to 79.00 yen. For details, please see the “Notice Concerning Dividends of Surplus (Increase in Dividend)” announced on May 13, 2026.

provided by StockWeather.com,Inc.